Skip to main content

Advertisement

Log in

Long-term prognostic factors for cardiovascular events in patients with chest pain without diabetes mellitus nor significant coronary stenosis

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

A Correction to this article was published on 29 March 2024

This article has been updated

Abstract

Chest pain is the most common symptom of coronary artery disease (CAD) and diabetes mellitus (DM) is a well-known single strongest risk factor for cardiovascular diseases. Thus, the impact of CAD nor DM on long-term clinical effects is reported widely, but the prognostic factors of non-DM patients presenting with chest pain without significant CAD are limited. A total of 1,046 patients with chest pain without DM and significant CAD who underwent coronary angiography (CAG) and acetylcholine (ACH) provocation tests were finally enrolled. Propensity score matching and multivariate Cox-proportional hazard ratio analysis were performed to adjust for baseline potential confounders. Major adverse cardiac and cerebrovascular events (MACCE) were defined as the composite of total death, myocardial infarction (MI), revascularization, stroke, and recurrent angina. This study aimed to evaluate the long-term prognostic factors for MACCE in patients with chest pain without DM and CAD up to 5 years. Coronary artery spasm (CAS) was the most common cause of chest pain. However, long-term MACCE of CAS was not worse than those of patients with chest pain without CAS when patients with CAS had subsequent optimal antianginal medication therapy. However, a recurrent chest pain remains a problem even with continuous antianginal medication therapy. Up to 5 years, the incidence of MACCE was in 7.3%, including recurrent angina 6.9%. Dyslipidemia (HR: 2.010, 95% CI 1.166–3.466, P = 0.012), mild–moderate (30–70%) coronary stenosis (HR: 2.369, 95% CI 1.118–5.018, P = 0.024), the use of aspirin (HR: 2.885, 95% CI 1.588–5.238, P < 0.001), and the use of nitrates (HR: 1.938, 95% CI 1.094–3.433, P = 0.023) were independent risk factors for MACCE. Among the patients with chest pain without DM and significant CAD, the incidence of MACE were rare, but recurrent angina was still a challenging problem who had treated with antianginal medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All data can be checked by sending an email to correspondence.

Change history

References

  1. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003

    Article  Google Scholar 

  2. Baek JY, Choi BG, Rha SW, Choi CU, Park CG, Seo HS, Oh DJ, Ahn TH, Chang K, Chae SC, Hur SH, Cha KS, Choi IH, Kim HS, Gwon HC, Kim YJ, Oh SK, Chae JK, Seong IW, Hwang KK, Kim CJ, Yoon JH, Hwang JY, Kim DI, Joo SJ, Jeong MH (2019) Comparison of two-year outcomes of acute myocardial infarction caused by coronary artery spasm versus that caused by coronary atherosclerosis. Am J Cardiol 124(10):1493–1500

    Article  PubMed  Google Scholar 

  3. Choi BG, Park SH, Rha SW, Park JY, Choi SY, Park Y, Xu S, Ngow HA, Ali J, Li H, Kim JB, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ (2015) Five-year clinical outcomes in patients with significant coronary artery spasm: a propensity score-matched analysis. Int J Cardiol 84:533–539

    Article  Google Scholar 

  4. Nam P, Choi BG, Choi SY, Byun JK, Mashaly A, Park Y, Jang WY, Kim W, Choi JY, Park EJ, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ, Rha SW (2018) The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis. Atherosclerosis 270:8–12

    Article  CAS  PubMed  Google Scholar 

  5. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U (2011) 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol 57(2):147–152

    Article  PubMed  Google Scholar 

  6. Choi BG, Rha SW, Yoon SG, Choi CU, Lee MW, Kim SW (2019) Association of major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean population. J Am Heart Assoc 8(12):e010541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kugiyama K, Murohara T, Yasue H, Kimura T, Sakaino N, Ohgushi M, Sugiyama S, Okumura K (1995) Increased constrictor response to acetylcholine of the isolated coronary arteries from patients with variant angina. Int J Cardiol 52(3):223–233

    Article  CAS  PubMed  Google Scholar 

  8. Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Ogawa H, Yoshimura M, Inobe Y, Hirashima O, Kawano H, Soejima H, Yasue H (1997) Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 30(4):920–926

    Article  CAS  PubMed  Google Scholar 

  9. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94(3):266–271

    Article  CAS  PubMed  Google Scholar 

  10. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A (2002) Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105(13):1545–1547

    Article  CAS  PubMed  Google Scholar 

  11. Mehta PK, Huang J, Levit RD, Malas W, Waheed N, Bairey Merz CN (2022) Ischemia and no obstructive coronary arteries (INOCA): a narrative review. Atherosclerosis 363:8–21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study. J Am Coll Cardiol 52(7):523–527

    Article  PubMed  Google Scholar 

  13. Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J (2007) Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Exp Clin Cardiol 12(1):17–28

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Choi BG, Rha SW, Park T, Choi SY, Byun JK, Shim MS, Xu S, Li H, Park SH, Park JY, Choi WG, Cho YH, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ (2016) Impact of cigarette smoking: a 3-year clinical outcome of vasospastic angina patients. Korean Circ J 46(5):632–638

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kang KW, Choi BG, Rha SW (2018) Impact of insulin resistance on acetylcholine-induced coronary artery spasm in non-diabetic patients. Yonsei Med J 59(9):1057–1063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Park Y, Choi BG, Rha SW, Baek MJ, Ryu YG, Choi SY, Byun JK, Shim MS, Mashaly A, Li H, Jang WY, Kim W, Kang JH, Choi JY, Park EJ, Park SH, Lee S, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ (2018) Selective ss1-blockers are not associated with new-onset diabetes mellitus in hypertensive patients. J Cardiovasc Pharmacol 71(1):38–45

    Article  CAS  PubMed  Google Scholar 

  17. American Diabetes A (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67-74

    Article  Google Scholar 

  18. Choi BG, Kim DJ, Baek MJ, Ryu YG, Kim SW, Lee MW, Park JY, Noh YK, Choi SY, Byun JK, Shim MS, Mashaly A, Li H, Park Y, Jang WY, Kim W, Kang JH, Choi JY, Park EJ, Park SH, Lee S, Na JO, Choi CU, Kim EJ, Park CG, Seo HS, Oh DJ, Rha SW (2018) Hyperuricaemia and development of type 2 diabetes mellitus in Asian population. Clin Exp Pharmacol Physiol 45(6):499–506

    Article  CAS  PubMed  Google Scholar 

  19. Rha SW, Choi BG, Seo HS, Park SH, Park JY, Chen KY, Park Y, Choi SY, Shim MS, Kim JB, Park T, Park J, Lee JJ, Park EJ, Park SH, Choi JY, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Oh DJ (2016) Impact of statin use on development of new-onset diabetes mellitus in asian population. Am J Cardiol 117(3):382–387

    Article  CAS  PubMed  Google Scholar 

  20. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research C (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344–2351

    Article  PubMed  Google Scholar 

  21. Kim JB, Choi BG, Rha SW, Seo HS, Choi SY, Byun JK, Na JO, Choi CU, Kim EJ, Park CG, Oh DJ (2018) Clinical characteristics and outcomes of patients with coronary artery spasm who initially presented with acute myocardial infarction. Coron Artery Dis 29(1):60–67

    Article  PubMed  Google Scholar 

  22. Ghosh S (2011) Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Expert Rev Cardiovasc Ther 9(3):329–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ishii M, Kaikita K, Sato K, Tanaka T, Sugamura K, Sakamoto K, Izumiya Y, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H (2015) Acetylcholine-provoked coronary spasm at site of significant organic stenosis predicts poor prognosis in patients with coronary vasospastic angina. J Am Coll Cardiol 66(10):1105–1115

    Article  CAS  PubMed  Google Scholar 

  24. Park T, Park JY, Rha SW, Seo HS, Choi BG, Choi SY, Byun JK, Park SH, Park EJ, Choi JY, Park SH, Lee JJ, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Oh DJ (2017) Impact of diltiazem alone versus diltiazem with nitrate on five-year clinical outcomes in patients with significant coronary artery spasm. Yonsei Med J 58(1):90–98

    Article  CAS  PubMed  Google Scholar 

  25. Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Momomura S, Yasuda S, Ogawa H, Shimokawa H, Japanese Coronary Spasm A (2015) Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J 36(4):228–237

    Article  CAS  PubMed  Google Scholar 

  26. Park JY, Rha SW, Poddar KL, Ramasamy S, Chen KY, Li YJ, Choi BG, Ryu SK, Choi JW, Park SH, Park S, Elnagar A, Im SI, Kim SW, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Han SW, Park CG, Seo HS, Oh DJ (2012) Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients. J Cardiol 60(3):187–191

    Article  PubMed  Google Scholar 

  27. Choi BG, Kim K-H, Rha S-W (2022) Safety and efficacy of low-dose aspirin in patients with coronary artery spasm: long-term clinical follow-up. Cardiovasc Prev Pharmacother 4(1):26–33

    Article  Google Scholar 

  28. Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, Tabata N, Arima Y, Sueta D, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H (2016) Impact of aspirin on the prognosis in patients with coronary spasm without significant atherosclerotic stenosis. Int J Cardiol 220:328–332

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Seung-Woon Rha or Byoung Geol Choi.

Ethics declarations

Conflict of interest

No potential conflicts of interest relevant to this article were reported. The authors have no conflicts of interest relevant to this study to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised due to the contribution statement was missing and included in this version.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rha, SW., Lee, K., Choi, S. et al. Long-term prognostic factors for cardiovascular events in patients with chest pain without diabetes mellitus nor significant coronary stenosis. Heart Vessels 39, 382–391 (2024). https://doi.org/10.1007/s00380-023-02348-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-023-02348-4

Keywords

Navigation